Figures 2From: Distinct signatures of the immune responses in low risk versus high risk neuroblastomaLR patients show higher titers of IL-10, IL-1β and MCP-1 in their sera. Multiplex cytokine array analyses of the sera of patients with LR and HR neuroblastoma for detected higher levels of IL-10 (A) IL-1β (B), and MCP-1 (C) in LR patients. Data represent 4-6 HR and 6-7 LR patients.Back to article page